Activitat in vitro de nous antifúngics i epidemiologia molecular de les infeccions per "Candida albicans"
Els avenços que han experimentat tots els camps de la medicina en els darrers 20 anys han influït de forma notable en els tipus de malalts que són atesos als centres hospitalaris, sobre tot en hospitals de tercer nivell. L'aplicació de noves tecnologies o actituds terapèutiques corn el trasplan...
Main Author: | Marco Reverté, Francesc |
---|---|
Other Authors: | Jiménez de Anta Losada, María Teresa |
Format: | Doctoral Thesis |
Language: | Catalan |
Published: |
Universitat de Barcelona
2002
|
Subjects: | |
Online Access: | http://hdl.handle.net/10803/31829 http://nbn-resolving.de/urn:isbn:978-84-694-4885-4 |
Similar Items
-
Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats
by: N. Chami, et al. -
In Vivo Comparative Evaluation of the Pomegranate (Punica granatum) Peel Extract as an Alternative Agent to Nystatin against Oral Candidiasis
by: Shahindokht Bassiri-Jahromi, et al.
Published: (2018-05-01) -
Candida albicans isolated from urine: Phenotypic and molecular identification, virulence factors and antifungal susceptibility
by: Laura Wiebusch, et al.
Published: (2017-07-01) -
Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
by: Amaral, J.L, et al.
Published: (2022) -
pH-Dependant Antifungal Activity of Valproic Acid against the Human Fungal Pathogen Candida albicans
by: Julien Chaillot, et al.
Published: (2017-10-01)